Skip to content

Comparison of Oral Melatonin and Oral Triclofos for use in sleep deprived sleep EEG in children

To compare the efficacy and safety of Melatonin and Triclofos as sedatives in children posted for sleep deprived drug induced sleep EEG: A double-blind, parallel design, randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023592
Enrollment
180
Registered
2020-02-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G40- Epilepsy and recurrent seizures Health Condition 2: Z728- Other problems related to lifestyle

Interventions

Intervention1: Oral Melatonin: Melatonin plays an important role in regulation of circadian rhythms. Due to its hypnotic properties and ability to reduce sleep latency in children, Melatonin has been

Sponsors

Dr Prashant Jauhari
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of either sex aged 1-8 years scheduled to have a sleep deprived sleep EEG recording at Pediatric EEG lab, Department of Pediatrics, AIIMS 2. Children who are sleep deprived as per the guidelines mentioned in the methodology section

Exclusion criteria

Exclusion criteria: 1. Children suffering from an acute upper respiratory tract infection 2. Children diagnosed with autism, ADHD or significant behavioural disorders on CBCL 3. Children already diagnosed with sleep related movement disorders 4. Children who have received any sedative medication (including investigation drugs) other than antiepileptics within the last 48 hours 5. Parents refusing consent for enrolment in the study 6. Children with status epilepticus within the last 48 hours

Design outcomes

Primary

MeasureTime frame
Sleep duration in minutes as measured by Paediatric Sedation State Scale. Timepoint: after 1st dose of the drug administered

Secondary

MeasureTime frame
5-point likert scale for parental satisfactionTimepoint: within 24 hours after performing EEG;Adequate sedation defined by achievement of Pediatric sedation state scale level 2 or less in minutesTimepoint: after first dose of drug administered;Drowsiness period in minutes as measured by Paediatric Sedation State Scale.Timepoint: after first dose of drug administered;Percentage of children having adverse effects within 24 hours after performing EEG (telephonically).Timepoint: within 24 hours after performing EEG;Percentage of children requiring second dose in each group.Timepoint: 30 minutes after administring first dose;Quality of EEG assessed by a self-designed EEG scoring systemTimepoint: after 20 minutes of EEG recording as per protocol

Countries

India

Contacts

Public ContactMiss Divya Sree Fachchi

All India Institute of Medical Sciences, New Delhi

pjauhari0@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026